Vitamin D and body mass index in Egyptian multiple sclerosis patients.

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc in the context of multiple sclerosis, published as an observational study.

This study aimed to assess the correlation between the serum level of 25(OH) vitamin D, body mass index (BMI) and the Expanded Disability Status Scale (EDSS) in a sample of Egyptian MS patients.

Why It Was Studied

Vitamin D deficiency and obesity may be related to the pathogenesis and disease activity of multiple sclerosis (MS).

Who Took Part

The study group was 130 patients.

The age groups tagged for this paper are young adults, adults and middle-aged adults, both men and women.

This was an observational study that included 130 MS patients who were recruited consecutively among the patients attending the MS unit of Ain Shams University Hospital, Cairo, in the period between December 2017 and March 2018.

How the Study Was Run

The serum level of 25(OH) D, BMI and EDSS were recorded.

What Was Measured

Topics PubMed links to this paper include Biomarkers, Body Mass Index, Cross-Sectional Studies, Disability Evaluation, Egypt, Multiple Sclerosis and Overweight.

The authors tagged it with the keywords BMI and Vitamin D.

What This Means in Plain Language

This is an observational study of Vitamin D, K2, Magnesium and Zinc in 130 patients in people with multiple sclerosis.

The abstract goes on to report its results in about 11 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2019 (Multiple sclerosis and related disorders), a journal based in Netherlands.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, Multiple sclerosis research.